Patent Application
20110060359
The invention relates to a device for the removal of foreign bodies and thrombi from body cavities and blood vessels using at least one guide wire provided with a distal element.
Thromboembolic diseases such as cardiac infarction, pulmonary embolism, peripheral thrombosis, organ embolisms etc. are typically caused by a thromboembolism (hereinafter for short thromb or thrombus), i.e. a visco-elastic blood clot comprising platelets, fibrinogen, coagulation factors etc. forming in a blood vessel which it obstructs either wholly or in part. The obstruction of organ arteries also leads to the supply of oxygen and nutrients to the associated tissue being interrupted. The disorder of the functional metabolism linked with functional losses is closely followed by a failure of the structural metabolism resulting in the relevant tissue becoming destroyed (infarction). Organs most frequently affected in this way are the heart and the brain. Nevertheless, the arteries of the limbs as well as pulmonary arteries are also impaired. Venous thromboses and thromboembolic occlusions are frequently occurring in the leg and pelvic veins. The disease pattern of the thrombotic occlusion of an intracranial sinus may lead to severe intracerebral hemorrhage due to a failure of venous drainage of brain tissue.
In view of the severity of the disease patterns associated with thromboembolism and the prevalence rate of such diseases various techniques have been developed aimed at dissolving or removing thrombi.
It is known in this context to treat such patients with thrombolytic agents such as streptokinase or urokinase or anticoagulants intended to achieve thrombolysis or limit the growth of thrombi. Since treatment methods of this kind are usually very time consuming they are frequently combined with invasions aimed at reducing the size of or removing the thrombus or embolus mechanically.
Aside from open surgical operations prior art techniques more and more embrace the use of transluminal or endovascular, catheter-guided interventional therapy methods because these are of less invasive nature. It is thus known to remove the thrombus from the patient's body by means of vacuum producing suction catheters or mechanically using catheters provided with capturing cages, helixes, hooks or similar elements; refer to U.S. Pat. No. 6,245,089 B1, U.S. Pat. No. 5,171,233 A1, Thomas E. Mayer et al., Stroke 2002 (9), 2232.
Disadvantages associated with the known transluminal devices are that with said devices it is often impossible to remove the thromb completely and, moreover, there is a risk of the thromb or fragments of it being released into the blood stream thus passing on to vessels of smaller lumen which are more difficult to be reached and treated. Furthermore, due to their size and/or low flexibility the devices known from prior art are only inadequately suited for the removal of thrombi from greatly convoluted vessels or those of particularly small lumen such as those in the brain.
From US 2002/0049452 a device with a catheter is known for the removal of thrombi to which distal end capture arms made of shape-memory material are attached which in their compressed state rest against the catheter and when expanded extend radially from the catheter outwards. When in expanded position which is caused by the body temperature the capture arms are intended to get caught in the thrombus and then retract it out of the blood vessel as the catheter is pulled back into another catheter. The drawback associated with this device is, however, that in order to cool and thus keep the capture arms below transformation temperature before they are released into the blood stream it must either be moved past the thrombus in a secondary catheter which brings about the cooling effect, or a heating system has to be arranged inside the catheter provided with the capture arms that enables the transformation temperature to be attained when the thrombus has been reached. Not only are the design requirements of this configuration very high and thus prone to disturbances it is also the sheer physical size of this device that rules out a treatment of vessels having a particularly small lumen.
In view of the disadvantages of these prior art devices it is thus the object of the invention to provide a device for the removal of foreign bodies and thrombi from body cavities and blood vessels which alleviates the surgical risk existing when removing thrombi and allows the treatment of vessels of especially small lumen.
According to the invention this objective is achieved by providing a device for the removal of foreign objects and thrombi from body cavities and blood vessels using at least one guide wire provided with a distal element, with said distal element being provided with fibers projecting radially outward and the device being provided with a cage or tubular structure which is suitable to be flatly collapsible under the external strain exerted by a micro-catheter and transported inside the micro-catheter and unfolds to its full cage or tubular structure when said external strain caused by the micro-catheter is omitted, with said distal element and the cage or tubular structure being designed so as to be longitudinally movable in relation to each other and the cage or tubular structure having an opening at the distal end through which the distal element can be introduced into said cage or tubular structure.
The basic principle of the invention involves the provision of a device that primarily is composed of two elements that by interaction enable thrombi to be safely eliminated from blood vessels. One of these elements is the distal element provided with fibers or bristles projecting radially outward whereas the other element constitutes the cage or tubular structure. The guide wire(s) designed so as to serve as insertion aid yield excellent maneuvering characteristics even in small-lumen and convoluted vessel segments. The fibers of the distal element are suited to capture and stabilize a thrombus, especially if they are made of or finished with thrombogeneous materials.
The device is transferred to the application site with the aid of a small-lumen micro-catheter. The device situated inside the micro-catheter may either be 1) maneuvered to the distal location of the thrombus and then retracted, 2) released from the micro-catheter in the area of the thrombus, or 3) pushed out of the micro-catheter at a point proximally to the thrombus and then penetrate the thrombus anterogradely. As long as the distal element is confined within the micro-catheter the flexible fibers are pressed against the distal element in proximal direction due to mechanical resistance. When the distal element has left the micro-catheter the fibers are capable of unfolding fully and for the main part protrude radially outward perpendicular to the distal element. For the purpose of removing a thrombus (clot) the procedure usually followed is to transport the distal element contained in the micro-catheter to a point distally of the dot since while being inside the micro-catheter the fibers are prevented from standing upright completely so that the diameter of the distal element in this condition is comparatively small. Distally of the clot the distal element will then be expelled from the micro-catheter so that its complete circumferential size unfolds due the fibers now moving into upright position. As a next step the micro-catheter may now be removed. Following this, the distal element is moved into proximal direction with the fibers taking the clot along. The fibers hook themselves into the clot and may thus also serve clot stabilizing purposes.
On the other hand, the cage or tubular structure that also forms part of the device is positioned proximally of the clot. Being retracted in proximal direction the distal element together with the clot can now be pulled through the distal opening of the cage or tubular structure into said structure, which secures the captured thrombus altogether, especially radially outward but, as the case may be, also in proximal direction. Subsequently, the entire device including cage or tubular structure and distal element is retracted farther until it is finally contained in a catheter which is then removed from the blood vessel system. In this manner, an efficient and safe removal of thrombi especially from small-lumen blood vessels can be realized.
As a rule, the latter catheter is a so-called guide catheter having an inner diameter greater than that of the micro-catheter used for the placement of the device. In this way, the entire thrombus as well as the device in its expanded state can be moved and placed into the guide catheter. During treatment also the micro-catheter is usually pushed forward through the guide catheter although said guide catheter can only be moved forward up to a certain point because in vessels of particularly small lumen, especially in intracranial areas, only the micro-catheter which has a very small diameter can be employed.
It is understood that for the intended purpose the fibers must have adequate stiffness but at the same time must be flexible or bendable enough so that they can be passed through a catheter and do not damage the vessel walls.
The fibers may consist of a natural substance, polymer material, monomers, metal, ceramic material, glass or a combination thereof. Especially preferred are polymer materials.
Suitable materials are primarily polyurethane, polyacrylics, polyester, polytetrafluoroethylene, polyamide or polyalkylene and, due to its peptide-like bond structure, most notably polyurethane and polyamide, e.g. nylon, which enables the thrombus to excellently anchor or “adhere” to the fibers.
Aside from polymer materials metals are also well suited for the intended purpose. Suitable metallic materials for treatment purposes are all metals that do not have detrimental effects on the patients. Especially suited for the described purpose are stainless steel fibers and fibers made of metal alloys having shape-memory properties such as for example nitinol fibers. Fibers made of shape-memory materials offer advantages in that when under the external strain exerted by a micro-catheter they are initially shaped to fit closely and after having been released from the micro-catheter assume a second shape allowing them to freely stick out perpendicularly. Furthermore, gold and platinum are suitable materials as well. Also suited are ceramic materials, fiber glass and carbon fibers.
The cage or tubular structure as well is transported through the micro-catheter in folded up condition. As soon as the external constraint exerted by the micro-catheter is omitted it is capable of unfolding to assume its full, expanded cage or tubular structure. Therefore, the cage or tubular structure preferably consists of a shape-memory material, in particular nitinol, because in this case an automatic or self-acting unfolding of the structure is effected after it has been pushed out of the micro-catheter.
The process of unfolding to the full cage or tubular structure upon omission of the external strain exerted by the micro-catheter must not necessarily take place automatically but may also be effected manually. For this purpose an additional guide wire is conceivable, for example, which upon being moved forward causes the structure to unfold.
Generally, the cage or tubular structure is of oblong, ship-like configuration of a length ranging between 5 and 50 mm with a diameter of between 2 and 6 mm in expanded state. Folding up of the cage or tubular structure in this case under the influence of an external constraint caused by a catheter is normally associated with a stretching of the cage structure. The cage or tubular structure in its entirety should be designed such that both unfolding when being moved out of the micro-catheter as well as collapsing when being retracted into the micro-catheter can take place without difficulty.
In the context of this invention the terms “distal” and “proximal” are to be understood as viewed from the direction of the attending physician. The distal end is thus the end situated away from the attending physician which relates to the components of the device advanced farther into the blood vessel system whereas proximal means facing towards the attending physician, i.e. the proximally arranged components of the device are introduced less far into the blood vessel.
If the phrase ‘longitudinal direction’ is used in this document it is to be understood as denoting the direction into which the device is advanced, i.e. the longitudinal axis of the device also coincides with the longitudinal axis of the blood vessel along which the device is moved forward.
To enable the cage or tubular structure on the one hand and the distal element on the other to be longitudinally movable in relation to each other, it is expedient to provide them with separate guide wires. In this manner the cage/tubular structure and the distal element can be moved independently of one another both in proximal and also distal direction. Especially, the distal element can be maneuvered to a point distally of the clot and then retracted proximally into the cage/tubular structure. Moreover, using separate guide wires makes it possible to easily advance the distal element farther into distal direction than the cage/tubular structure.
In accordance with an alternative embodiment the device may as well be provided with only a single guide wire to which distal end the distal element is attached, with the cage or tubular structure being arranged on the guide wire so as to be movable longitudinally. Important in this respect is that also with a single guide wire the longitudinal movability of the two main components of the device is ensured.
To have adequate control over the cage/tubular structure in the event of the embodiment provided with a single guide wire it is considered expedient to arrange two stops on the guide wire between which the cage/tubular structure can be moved longitudinally along the guide wire. In this case the stop element located farther proximally, which may, for example, be welded onto the guide wire, abuts against the cage/tubular structure when being moved forward so that said structure is carried along in distal direction. When the guide wire is retracted, however, the farther distally located stop element abuts on the cage/tubular structure causing it to be carried along in proximal direction. While with the embodiment provided with only a single guide wire there is less freedom of placement of the cage/tubular structure and distal element, it still offers other advantages, however, in that it is of simpler design.
To make sure the cage/tubular structure is moved along by action of the stop elements on the guide wire, it may, at least at one point, preferably at the proximal end, narrow to such an extent that the inner diameter of the cage/tubular structure at this point is smaller than the outer diameter of the stop elements arranged on the guide wire. For example, the cage/tubular structure may converge in a sleeve-like object which is hollow inside so that the guide wire is capable of passing through the sleeve-like object, while the diameter of the two stop elements, however, is too large for them to pass through the sleeve-like object. In this way, the cage/tubular structure is freely movable on the guide wire between the two stop elements but not beyond said elements.
Since the cage/tubular structure serves to secure the thrombus drawn into it together with the distal element, said structure may be provided with a polymer skin arranged on its radial outer side. Such a polymer skin ensures that no fragments of the clot are permitted to escape to the outside and, moreover, makes sure the clot is protected against influences exerted by the inner wall of the vessels.
Such a polymer material may preferably be polyurethane, but other polymers, such as, for example, PTFE (polytetrafluoroethylene), may also be used for manufacturing purposes.
Alternatively or additionally to a polymer skin the cage structure may also be provided with a fiber or wire braiding or mesh on its radial outer side. Such a braiding or mesh should be dense enough to enable the clot mass to be retained without difficulty. In case a wire mesh is used, it is thought expedient to also use a material having shape-memory properties, in particular nitinol, for its manufacture.
At its proximal end the cage structure may be closed. In this manner, the clot mass can also be safely secured in proximal direction. However, a cage structure closed off at the proximal end is not absolutely necessary; in fact, also a cage or tubular structure may be used that provides for clot securing in radial direction only because by action of the fiber-covered distal element the clot is retained in longitudinal direction anyway. In this case the configuration can rather be viewed as a tubular than a cage structure.
The cage structure may be composed of three or more, in particular four to six braces extending in longitudinal direction. It is to be noted in this respect that by ‘braces extending in longitudinal direction’ not only braces are meant that are arranged exactly in parallel to the longitudinal axis but also those extending at a certain degree of <90° to the longitudinal axis in distal or proximal direction. As mentioned above with respect to the cage structure the braces preferably consist of a material having shape-memory characteristics.
The braces must be designed so as to be collapsible when the system is retracted into the micro-catheter. Moreover, the braces also serve to enable a polymer skin, if applicable, to spread out. The braces may also serve as a basic supporting structure for a fiber or wire mesh arranged on the radial outer side of the cage structure. If thought expedient, further wires, preferably nitinol wires, may be mounted between the braces, said wires serving as limiting elements and support for the polymer skin or fiber/wire mesh.
The braces of the cage structure may also consist of a wire arranged in the form of loops. Such a wire may extend from proximal to the distal end where it forms a loop, extends back in proximal direction and having formed into another loop runs back in distal direction. If required, additional loops may be provided in the wire configuration such that the total number of braces is increased in this way. If necessary, cross braces may be arranged between these braces. Since the braces in this case are composed of wires configured such that they form into one or several loops, the number of free wire ends is kept small which also reduces the risk of vessel wall injuries. Otherwise, the wire ends would need to be rounded, possibly, or provided with rounded terminating elements.
In accordance with another embodiment the braces starting out from the proximal end of the cage structure extend radially outward, continue in longitudinal direction distally and, having formed into a loop, partially run back in proximal direction along the circumference of the cage structure. In this case as well the braces may serve as securing points for polymer skin or a fiber/wire mesh or braiding. Furthermore, due to the fact that the braces at the distal end of the cage structure form into a loop a rounding is provided in this location and minimizes the risk of injuries to the wall of the vessel. In the distal area the individual braces may be connected with each other by (laser) spot welds and/or by spiral sleeves. Spiral sleeves of this type may have an oval cross section because two braces are accommodated within this cross section, said braces being interconnected by the spiral sleeve.
As per an alternative embodiment the cage/tubular structure is designed in the form of a tubular structure composed of a rolled metal sheet. In this case the structure is not closed at the proximal end. Moreover, on account of the closed surface of such a tubular structure made of a rolled-in metal sheet no polymer skin or braided structure is required on the radial outer side because the clot is secured by the metal sheet itself. Preferably, the sheet in this case as well consists of a material having shape-memory properties, in particular nitinol, so that a self-expanding tube is provided which increases its diameter automatically upon being pushed out of a micro-catheter. To enable such an expansion to take effect the tube, preferably, is not closed radially but the edges extending in longitudinal direction overlap to a certain extent. The tubular structure after expansion should as a maximum have a diameter preventing the lateral slot from being open, with the edges extending in longitudinal direction abutting at the most. In this way, it can be ensured that the captured clot is secured and held over the entire circumference. Such a tubular structure may of course be used both in the framework of a device provided with two guide wires and in the framework of a device with a single guide wire only.
To enable the cage/tubular structure to be inserted in and removed from the micro-catheter without difficulty it is considered expedient to design said structure such that it terminates in a single point at its proximal end. In case of a cage structure formed by braces this is ensured in particular by arranging for the proximal ends of the braces to converge centrally and be connected with each other. For example, the braces may terminate in a common sleeve. In the event of an embodiment of the device with a single guide wire only such a sleeve may be hollow inside so that it can be moved on the guide wire in longitudinal direction between two stop elements. In case of an embodiment comprising two guide wires it is expedient, however, to connect such a sleeve directly with one of the guide wires.
In case of a tubular structure consisting of a rolled-in metal sheet rolling of the sheet may be brought about in that the longitudinal edges of the sheet each overlap proximally and distally on one side so that in this case as well the tubular structure converges in one point at least proximally. The metal sheet in this case is rolled slightly diagonally. However, such an embodiment differs from the one described above in that the point on which the structure converges at the proximal end is located on the radial circumference of the tubular structure and not in the center of it.
A structure tapering at the proximal end and converging at a connection point is also viewed expedient because if wrongly positioned the cage or tubular structure can be retracted into the catheter without problems so that it may again be discharged after the catheter has been repositioned. As a result of its tapering structure the cage/tubular structure entering the micro-catheter curls up more closely and again assumes its volume-reduced form with the pull force applied to the guide wire and the forces exerted via the catheter rim interacting.
Particularly suitable for the treatment of vessels of especially small lumen are fibers having a length of 0.5 to 6 mm and preferably 1.2 to 3 mm so that an outer diameter of 1 to maximum 12 mm of the fiber-carrying part of the distal element is attained even when the fibers are arranged radially. For a particularly atraumatic treatment such outer diameter may be slightly smaller than the inner diameter of the relevant blood vessel.
Expediently, the fibers extend over a distal element length ranging between 0.5 and 5 mm. To make sure the thrombus is sufficiently anchored it is expedient if the fibers are arranged on the distal element of the guide wire with a density ranging between 20 and 100 per cm.
Expediently, the guide wire is made of a medical stainless steel or shape-memory material, preferably nitinol. It is expedient in this case to provide a guide wire/guide wires having an outer diameter ranging between 0.2 and 0.4, preferably between 0.22 and 0.27 mm. A typical guide wire length ranges between 50 and 180 cm.
In accordance with another advantageous design of the device the fibers are arranged spirally along the longitudinal axis of the distal element. This embodiment is especially suited for “piercing” or penetrating into the thrombus as the fiber-carrying portion of the distal element works in the same way as a corkscrew if appropriately manipulated by the attending physician.
In conformity with another advantageous embodiment of the invention the distal element with its radially projecting fibers has a tapered structure after it has been discharged from the micro-catheter, i.e. the radial extension of the fibers which in fact corresponds to the diameter of the distal element increases from proximal to distal. The main advantage of such a tapered “brush form” is that irrespective of the width of the blood vessel to be cleaned at a time there are always at least some portions the fibers of which are of optimum length. Fibers have an optimum length for a given blood vessel especially if the fibers contact the walls of the blood vessel in such a way that they are not bent in distal direction when the device is moved proximally. In this case the cleaning efficiency of the fibers is particularly good. Longer fibers, on the other hand, are bent distally during the return movement in proximal direction so that their cleaning efficiency diminishes whereas short fibers may not even reach the inner wall of the vessel and are thus incapable of providing a cleaning effect at that location anyway.
Additionally or alternatively the fibers in the proximal area of the distal element may also be designed to be harder than in the distal area. The harder fibers in the proximal area in this case mainly serve to scrape off a thrombus adhering to the vessel wall while the softer fibers in the distal area primarily serve to secure or retain the thrombus or fragments of a thrombus.
The fibers to be used according to the invention preferably project at an angle ranging between 70° and 110°, preferably at an angle of between 80° and 90° from the longitudinal axis of the device. These angle indications are to be understood such that angles <90° characterize a proximal orientation of the fibers whereas angles >90° signify a distal orientation of the fibers. Embodiments providing for an angle which is slightly smaller than 90° are particularly atraumatic upon forward movement in the vessel or through the thrombus and at the same time result in an especially effective anchoring within the thrombus when being retracted.
The fibers may be attached to the distal element by braiding, clamping, bonding, knotting, welding and/or fusing. Techniques which are aimed at connecting fibers in this manner are, for example, known from the fabrication of fiber-equipped embolization spirals.
In accordance with an especially preferred embodiment the distal element is manufactured in such a way that the fibers are placed adjacent to each other and, if so desired, additionally superimposed on each other between two core wires, with said fibers extending orthogonally to the core wires. It is to be noted in this context that according to the invention an orthogonal extension shall not exclusively mean an angle of exactly 90° but rather any transverse configuration of the fibers in relation to the core wires, i.e. the fibers primarily extend transversely to the core wires, not in parallel. Accordingly, also angles of for instance 70° may be viewed as being orthogonal in the framework of the invention. After the fibers have been placed between the core wires, said wires are twisted together, for example in that one end is fixed while the other one is turned or twisted around the other to bring about a plastic deformation of the core wires thus forming into a spiral structure. After the core wires have been twisted together the fibers project outwardly from the twisted core wires virtually in the form of a helical line. The significant advantage of such a distal element is that relatively little core wire is required to achieve a very high fiber coverage. The use of core wires also offers benefits in that the system retains high flexibility. Moreover, fixing the fibers at the core wires in this embodiment is particularly simple and results in the fibers to be distributed in a particularly uniform manner.
Quantity as well as density of the fibers can be controlled, inter alia, via the number of core wire twistings or windings so that different hardness characterstics can be produced with respect to the radial force exerted by the brush-shaped distal element because the higher the number of windings the more fibers can be arranged per unit of length. Moreover, the bending stiffness can be adjusted, inter alia, via the number of core wires and twistings provided.
If thought expedient, the devices may be provided with several distal elements from which fibers stick out radially. Such a system may, for example, offer benefits if particularly large thrombi or, as the case may be, several thrombi have to be eliminated from the blood vessel system. Furthermore, a fiber-covered element located farther distally may serve, if need be, to intercept and remove fragments of a thrombus that detach from and fall off the distal element situated farther proximally.
To enable an adequate flexibility to be achieved despite the length of such a system it is considered expedient to interconnect the individual distal elements by means of connecting elements, especially articulated joints. Such an articulated joint makes it possible for the device to perform within certain limits bending movements and thus follow the configuration of the blood vessels.
The fiber ends located radially outward are provided, beneficially, with dubs or thicker nubs, for example of spherical shape, so that increased surface is available for better clot mass retention. Another advantage of this embodiment makes it possible in this way to provide fiber ends that have an atraumatic effect. The thicker nubs at the ends of the fibers may for example be produced by cutting the fibers with the aid of methods like micro-laser cutting, electron beam cutting etc.
In accordance with another embodiment the fiber ends located radially outward are at least partially connected with each other via loops. The fibers connected in this manner thus comprise or are made up by a single fiber and not two fibers with the single fiber having a loop-shaped configuration. The fiber projects radially outward, extends up to the outer limit of the expanded distal element, forms a loop and runs back to the center of the distal element. The fibers in this case extend such that an elliptical shape is formed. This embodiment offers advantages in that, similar to the thicker nubs at the end of the fiber, there is a larger surface available for clot mass retention which results in the thrombus capturing effect being improved. Furthermore, the roundness of the loop makes it atraumatic. Also beneficial is that the fibers have increased stiffness due to the loop-shaped fiber configuration exhibiting a behavior similar to that of two fibers arranged side by side.
It may also be advantageous as the case may be if the fibers protrude, at least partially, differently far radially outward at the sides of the distal element. Similar to the embodiment described hereinbefore in which the radial expansion of the distal element increases from proximal to distal it is achieved in this manner as well that there are always at least some fibers available that are of optimum length to yield the respective cleaning effect. Inter alia, this may be brought about by arranging for the wire(s) from which the fibers of the distal element emanate to extend outside of the center, i.e. extend eccentrically. In this way, relatively short fibers are located on one side whereas relatively long fibers exist on the other side. As a result of their short distance to the point of attachment the short ends of the fibers have significantly harder characteristics and the long ends are significantly softer so that in this case as well the harder fibers rather improve the cleaning effect whereas the softer fibers enable a better retention of the captured thrombus. A distal element with eccentrically arranged wire configuration may offer still another advantage in that such a distal element can be maneuvered past the side of a clot more easily and then accommodate it when retraction in proximal direction takes place.
As per a particularly preferred embodiment of the device the fibers are coated. For example, this coating may be a neutral one consisting of Parylene or polytetrafluoroethylene (Teflon), but may also be a reactive coating, for example one that comprises collagen or consists of a material conducive to blood coagulation, preferably having one or several coagulation factors. This embodiment serves to strengthen the anchorage of the fibers inside the thrombus and alleviates the risk of the thrombus disintegrating to such an extent that fragments of it remain in the blood vessel or may be allowed to be released in the blood stream. Alternatively, the device may, entirely or partially, be coated/impregnated with a thrombolytic material to enable the thrombus to be more easily dissolved or facilitate its detachment and decomposition.
Surprisingly, it has been found that a thrombogeneous finishing of the fibers resulted in a significant stabilization of the thrombus at the device provided according to the invention. In this context it is left to the surgeon to bring the inventive device into contact with the thrombus and maintain this contact for a certain period of time thus allowing the thrombogeneous elements to promote an “adherence” of the thrombus to the device. Such an adherence to thrombogeneous fibers is achieved after a relatively short period, even within a few minutes at times. Not only does this preclude the disintegration of the thrombus as it is encountered with many devices, also the retraction of the thrombus into the catheter and its extraction from the vascular system is facilitated in this manner. Especially suited thrombogeneous materials and coatings for this purpose are known from literature to those skilled in the art. Especially suitable to this end are, for example, one or several of the factors fibrin, thrombin, factor XIII and/or factor VIII.
As an alternative to the thrombogeneous finishing of the fibers especially the fibers but also other parts of the device may be provided with a thrombolytic finishing so that a dissolution of the thrombus can be effected, at least partially, in this manner. A disintegration of the thrombus into individual fragments may be helpful and facilitate its removal with the aid of the fibers and/or cage structure, or, as the case may be, together with an aspiration catheter. In this case, the fibers of the inventive device having passed the thrombus in the direction of the blood flow act as filter and in this way prevent the fragments of the thrombus from being flushed away thus making it easier to capture the fragments.
Suitable thrombolytic or fibrinolytic agents are all those that are commonly known to possess the required properties. These are, for example, also the thrombolytic agents of the first generation, in particular streptokinase, anistreplase and urokinase which act as plasminogen activators. However, especially preferred are thrombolytic agents that, for example, activate plasminogen bonded to fibrin and are thus independent of the plasminogen circulating in the bloodstream. To be named in this context are thrombolytic agents of the second generation, in particular t-PA (alteplase) and fibrinolytic agents derived therefrom such as also saruplase. In this connection reference is made to S. Ueshima and O. Matsuo, Current Pharmaceutical Design 2006, 12, 849 et seq., “Development of New Fibrinolytic Agents”. Moreover, also suitable are fibrolases won from snake venom (Copperhead) and available in modified, recombinant form that show a direct proteolytic activity against the fibrinogen Aα chain. The fibrolase is a known fibrinolytic zinc metalloproteinase. Thrombolysis in this case is achieved irrespective of the formation of plasmin.
It is to be understood that each individual element of the inventive device that may have contact with the thrombus may be provided with an appropriate thrombolytic or fibrinolytic finish. This applies, in particular, to the fibers of the distal element but also to the cage structure, with said structure in this case preferably not being provided with a polymer skin. It shall also be understood that an appropriate thrombolytic or fibrinolytic finishing may also be applied to any other device intended for the removal of blood clots from the vascular system, for example to devices that have only be provided with the fiber-equipped distal element or to pure cage structures exclusively used for the detachment and capture of a blood clot.
It is, furthermore, advantageous if the fiber-covered distal element is a little longer than the cage/tubular structure. It is ensured in this manner that after the distal element has been drawn into the cage/tubular structure detached thrombus fragments are intercepted within the distal zones of the distal element. The cage/tubular structure is quasi closed off at the distal end by action of the projecting fibers of the distal element. Especially, if the guide catheter has a comparatively small inner diameter in relation to the outer diameter of the device it can be prevented in this manner that the clot mass is squeezed out when the guide catheter is being retracted.
Advantageously, the device is provided with one or several radiopaque markers. These may, for example, consist of platinum or a platinum alloy. Radiopaque markers of this kind may be located both in the area of the distal element and in the area of the cage/tubular structure so that the attending physician will be able to monitor the positioning relative to each other and thus the treatment progress with the help of image-forming methods conducive to the purpose.
Moreover, it is considered advantageous if the tip of the entire device is designed so as to be atraumatic, i.e. is rounded off for example.
Eventually, the invention also relates to the combination of the device with a guide and/or micro-catheter in which the device is maneuvered to the application site and when filled with the thrombus removed from the blood vessel system. It may be expedient to additionally design the catheter in the form of an aspiration catheter capable of accommodating micro-catheters.
The aspiration catheter is especially useful in connection with the above described thrombolytic or fibrinolytic finishing of a device for the removal of blood clots, irrespective of the design or configuration of such a device. The above also applies in the context of the devices described hereinbefore that have been provided with the fiber-covered distal element only and is also true for devices that constitute a pure cage structure.
The above described invention is of special significance to the removal of thrombi from vessels of especially small lumen, in particular intracranial vessels. The invention may of course be used also for the elimination of thrombi from other parts of the body, for example the heart, lungs, legs etc. However, the invention may also be used for the removal of other foreign objects from blood vessels, for example removing embolization spirals and stents.
Further elucidation of the invention is provided through the enclosed figures, where
a, b, c illustrate an alternative configuration of the braces forming a cage structure;
a shows the connection of braces forming a cage structure in the distal area using spiral sleeves;
b is a cross-sectional view of the cage structure shown in
Along the radial circumference the cage structure 1 is provided with a polymer skin 9 which serves the purpose of additionally securing a captured thrombus. Distal element 2 and guide wire 6 are connected with each other via a micro-coil 10. At the distal end the entire device is provided with a distal tip 11 that is of rounded design and thus has an atraumatic effect. The distal element 2 in its entirety has a tapered structure since the length of fibers 3 increases from proximal to distal. Such an embodiment has the benefit in that irrespective of the width of the blood vessel there are always fibers 3 that are of optimum length. Moreover, during the retraction process the longer fibers 3 arranged in the distal area of the distal element 2 are capable of capturing fragments that may detach from thrombus 5.
In
In
From
When moving the entire system forward through the micro-catheter the cage structure as well is pushed into distal direction due to the effect of the proximal stop element 14. After the distal element 2 has been released at a point distal to thrombus 5 the micro-catheter is retracted in order to liberate also the cage structure 1 proximal to thrombus 5. As a rule, said structure maintains its axial position in blood vessel 12 on account of the sufficiently high radial forces it exerts. In the event the cage structure 1 does not maintain its axial position on its own and move in proximal direction the micro-catheter 13 may be used to provide assistance in securing cage structure 1 in that micro-catheter 13 either is retracted just to such an extent initially that the cage structure 1 is permitted to unfold completely or, later, is again moved forward up to the cage structure 1.
Subsequently, as described above, the distal element 2 is retracted with a view to capturing the thrombus 5 until finally the distal element 2 and the thrombus 5 are contained in cage structure 1. When the device is retracted further also the cage structure 1 is moved in proximal direction because the distal stop element 14 carries cage structure 1 along. To complete the process the entire device may be withdrawn in proximal direction into a guide catheter and then removed.
In
As is shown in
b is a cross-sectional representation of
In
In
The cage structure 1 which is located distally to the tapered brush and may, for example, be made of nitinol strips the thrombus off the inner wall of the vessel upon retraction of the device and, if need be, divides it into smaller fragments. In the event of a fibrinolytic coating such a fragmentation effect will even be increased. The micro-brush 2 serves the function of “sweeping” the thrombus and its fragments in proximal direction.
Other than shown in
Since in the embodiment as per
Such a structure is especially suitable for convoluted vessels because it is less heavily deformed and “ovalized” by laterally exerted influences than is the case with cage structures having a more tubular shape.
In conclusion,
As explained earlier, the above described cage structures are suitable for the detachment and capture of blood clots both in the configuration involving a combination of cage and micro-brush and also in the form of simple structures. All the structure are very well suited for application also in conjunction with fibrinolytic agents, for example by a simple impregnation with a solution containing the appropriately diluted fibrinolytic agent. In regard to
| Number | Date | Country | Kind |
|---|---|---|---|
| 10 2006 044 831.6 | Sep 2006 | DE | national |
| Filing Document | Filing Date | Country | Kind | 371c Date |
|---|---|---|---|---|
| PCT/EP07/08191 | 9/20/2007 | WO | 00 | 7/30/2009 |
